发明名称 Cloning and expression of beta APP-C100 receptor (C100-R)
摘要 The present invention relates to the cloning of beta APP-C100 receptor (C100-R), and genetically engineered host cells which express the C100-R. Such engineered cells may be used to evaluate and screen drugs and analogs of beta -APP involved in Alzheimer's Disease.
申请公布号 US6083713(A) 申请公布日期 2000.07.04
申请号 US19950559397 申请日期 1995.11.15
申请人 BRISTOL-MYERS SQUIBB COMPANY;MCLEAN HOSPITAL CORPORATION 发明人 MANLY, SUSAN P.;KOZLOWSKI, MICHAEL R.;NEVE, RACHAEL L.
分类号 G01N33/53;A61K31/00;A61K31/70;A61K31/7088;A61K38/00;A61K39/395;A61P25/28;C07K14/47;C07K14/705;C07K16/28;C07K19/00;C12N1/21;C12N5/10;C12N15/00;C12N15/09;C12N15/113;C12N15/12;C12P21/02;C12P21/08;C12Q1/68;C12R1/91;G01N33/566;G01N33/577;G01N33/68;(IPC1-7):C12N15/12;C12N15/70;C12N15/85 主分类号 G01N33/53
代理机构 代理人
主权项
地址